Relatlimab
ATC — · 8 markets · 10 records
Relatlimab
Forms
AU 3 records · 3 strengths
- 80 mg/20 mLinjectionOPDUALAG
- 85.2 mginjectionOPDUALAG nivolumab 240mg and relatlimab 80mg in 20mL concentrate solution for IV infusion vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名OPDUALAG ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 strengths
- 4 mginjectionOPDUALAG
GB 1 records · 1 strengths
- 80 mg/20 mLinjectionOpdualag 240mg/20ml / 80mg/20ml concentrate for solution for infusion vials
CA 1 records · 1 strengths
- 4 mg/1 mLliquidOPDUALAG
SG 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG ×1
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名OPDUALAG ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 strengths
- 4 mg/1 mLinjectionOPDUALAG 240 mg/80 mg, solution à diluer pour perfusion
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.